Exploring Salivary Epithelial Dysfunction in Sjögren's Disease

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2024 May 11

PMID 38732189

Authors

Braxton Noll

Micaela Beckman

Farah Bahrani Mougeot

Jean-Luc Mougeot

Affiliations

Soon will be listed here.

Abstract

Sjögren's Disease (SjD) is an autoimmune disease of the exocrine tissues. Etiological events result in the loss of epithelial homeostasis alongside extracellular matrix (ECM) destruction within the salivary and lacrimal glands, followed by immune cell infiltration. In this review, we have assessed the current understanding of epithelial-mesenchymal transition (EMT)-associated changes within the salivary epithelium potentially involved in salivary dysfunction and SjD pathogenesis. We performed a PubMed literature review pertaining to the determination of pathogenic events that lead to EMT-related epithelial dysfunction and signaling in SjD. Molecular patterns of epithelial dysfunction in SjD salivary glands share commonalities with EMT mediating wound healing. Pathological changes altering salivary gland integrity and function may precede direct immune involvement while perpetuating MMP9-mediated ECM destruction, inflammatory mediator expression, and eventual immune cell infiltration. Dysregulation of EMT-associated factors is present in the salivary epithelium of SjD and may be significant in initiating and perpetuating the disease. In this review, we further highlight the gap regarding mechanisms that drive epithelial dysfunction in salivary glands in the early or subclinical pre-lymphocytic infiltration stages of SjD.

Citing Articles

Updating on the Dual Role of Salivary Gland Epithelial Cell (SGEC) in Sjögren's Disease.

Zhu W, Lu Y, Zhu Y, Huang X, Wang Y J Inflamm Res. 2025; 18:3039-3053.

PMID: 40046682 PMC: 11881760. DOI: 10.2147/JIR.S509220.

A Review of the Impact of Sjögren's Syndrome and/or the Presence of Anti-Ro/SS-A Antibodies on Therapeutic Strategies for Rheumatoid Arthritis.

Horai Y, Kurushima S, Shimizu T, Nakamura H, Kawakami A J Clin Med. 2025; 14(2).

PMID: 39860574 PMC: 11766391. DOI: 10.3390/jcm14020568.

Recent Advances in Pathogenesis, Diagnostic Imaging, and Treatment of Sjögren's Syndrome.

Horai Y, Shimizu T, Nakamura H, Kawakami A J Clin Med. 2024; 13(22).

PMID: 39597832 PMC: 11595189. DOI: 10.3390/jcm13226688.

Role of ncRNAs in the Pathogenesis of Sjögren's Syndrome.

Al-Haidose A, Hassan S, Elhassan M, Ahmed E, Al-Riashi A, Alharbi Y Biomedicines. 2024; 12(7).

PMID: 39062113 PMC: 11274537. DOI: 10.3390/biomedicines12071540.

References

Shah N, Noll B, Padilla R, Brennan M, Mougeot F, Mougeot J . Expression of ETS1 and LEF1 in salivary glands of Sjögren syndrome patients. Oral Dis. 2018; 25(1):164-173. DOI: 10.1111/odi.12985. View

Noll B, Bahrani Mougeot F, Brennan M, Mougeot J . Regulation of MMP9 transcription by ETS1 in immortalized salivary gland epithelial cells of patients with salivary hypofunction and primary Sjögren's syndrome. Sci Rep. 2022; 12(1):14552. PMC: 9411565. DOI: 10.1038/s41598-022-18576-z. View

Kakugawa T, Sakamoto N, Ishimoto H, Shimizu T, Nakamura H, Nawata A . Lymphocytic focus score is positively related to airway and interstitial lung diseases in primary Sjögren's syndrome. Respir Med. 2018; 137:95-102. DOI: 10.1016/j.rmed.2018.02.023. View

Cox T, Erler J . Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer. Dis Model Mech. 2011; 4(2):165-78. PMC: 3046088. DOI: 10.1242/dmm.004077. View

Thorlacius G, Bjork A, Wahren-Herlenius M . Genetics and epigenetics of primary Sjögren syndrome: implications for future therapies. Nat Rev Rheumatol. 2023; 19(5):288-306. PMC: 10010657. DOI: 10.1038/s41584-023-00932-6. View

Wise C, Woodruff R . Minor salivary gland biopsies in patients investigated for primary Sjögren's syndrome. A review of 187 patients. J Rheumatol. 1993; 20(9):1515-8. View

Sisto M, Lorusso L, Tamma R, Ingravallo G, Ribatti D, Lisi S . Interleukin-17 and -22 synergy linking inflammation and EMT-dependent fibrosis in Sjögren's syndrome. Clin Exp Immunol. 2019; 198(2):261-272. PMC: 6797899. DOI: 10.1111/cei.13337. View

Wu D, Witt R, Harrington D, Farach-Carson M . Dynamic Assembly of Human Salivary Stem/Progenitor Microstructures Requires Coordinated αβ Integrin-Mediated Motility. Front Cell Dev Biol. 2019; 7:224. PMC: 6843075. DOI: 10.3389/fcell.2019.00224. View

Sisto M, Lisi S, Ribatti D . The role of the epithelial-to-mesenchymal transition (EMT) in diseases of the salivary glands. Histochem Cell Biol. 2018; 150(2):133-147. DOI: 10.1007/s00418-018-1680-y. View

10.

Holdgate N, St Clair E . Recent advances in primary Sjogren's syndrome. F1000Res. 2016; 5. PMC: 4916986. DOI: 10.12688/f1000research.8352.1. View

11.

Bharaj T, Aqrawi L, Fromreide S, Jonsson R, Brun J, Appel S . Inflammatory Stratification in Primary Sjögren's Syndrome Reveals Novel Immune Cell Alterations in Patients' Minor Salivary Glands. Front Immunol. 2021; 12:701581. PMC: 8311440. DOI: 10.3389/fimmu.2021.701581. View

12.

Nikolov N, Illei G . Pathogenesis of Sjögren's syndrome. Curr Opin Rheumatol. 2009; 21(5):465-70. PMC: 2766246. DOI: 10.1097/BOR.0b013e32832eba21. View

13.

Li Y, He J, Wang F, Wang X, Yang F, Zhao C . Role of MMP-9 in epithelial-mesenchymal transition of thyroid cancer. World J Surg Oncol. 2020; 18(1):181. PMC: 7376963. DOI: 10.1186/s12957-020-01958-w. View

14.

Perez P, Kwon Y, Alliende C, Leyton L, Aguilera S, Molina C . Increased acinar damage of salivary glands of patients with Sjögren's syndrome is paralleled by simultaneous imbalance of matrix metalloproteinase 3/tissue inhibitor of metalloproteinases 1 and matrix metalloproteinase 9/tissue inhibitor of.... Arthritis Rheum. 2005; 52(9):2751-60. DOI: 10.1002/art.21265. View

15.

Fujita-Yoshigaki J, Matsuki-Fukushima M, Sugiya H . Inhibition of Src and p38 MAP kinases suppresses the change of claudin expression induced on dedifferentiation of primary cultured parotid acinar cells. Am J Physiol Cell Physiol. 2008; 294(3):C774-85. DOI: 10.1152/ajpcell.00472.2007. View

16.

Parisis D, Chivasso C, Perret J, Soyfoo M, Delporte C . Current State of Knowledge on Primary Sjögren's Syndrome, an Autoimmune Exocrinopathy. J Clin Med. 2020; 9(7). PMC: 7408693. DOI: 10.3390/jcm9072299. View

17.

Zhang J, Jamaluddin M, Zhang Y, Widen S, Sun H, Brasier A . Type II Epithelial-Mesenchymal Transition Upregulates Protein N-Glycosylation To Maintain Proteostasis and Extracellular Matrix Production. J Proteome Res. 2019; 18(9):3447-3460. PMC: 7195216. DOI: 10.1021/acs.jproteome.9b00342. View

18.

Pertovaara M, Korpela M, Uusitalo H, Pukander J, Miettinen A, Helin H . Clinical follow up study of 87 patients with sicca symptoms (dryness of eyes or mouth, or both). Ann Rheum Dis. 1999; 58(7):423-7. PMC: 1752915. DOI: 10.1136/ard.58.7.423. View

19.

Risselada A, Kruize A, Goldschmeding R, Lafeber F, Bijlsma J, van Roon J . The prognostic value of routinely performed minor salivary gland assessments in primary Sjögren's syndrome. Ann Rheum Dis. 2014; 73(8):1537-40. DOI: 10.1136/annrheumdis-2013-204634. View

20.

Fayyaz A, Kurien B, Scofield R . Autoantibodies in Sjögren's Syndrome. Rheum Dis Clin North Am. 2016; 42(3):419-34. PMC: 4955792. DOI: 10.1016/j.rdc.2016.03.002. View